Contact UsCompany ProfileHome
Saaskin Technologies
Send Inquiry Send SMS
Snibe MAGLUMI FK506 (CLIA) Snibe MAGLUMI FK506 (CLIA) Snibe MAGLUMI FK506 (CLIA)
Snibe MAGLUMI FK506 (CLIA)
Snibe MAGLUMI FK506 (CLIA) Snibe MAGLUMI FK506 (CLIA)

Snibe MAGLUMI FK506 (CLIA)

Product Details:

  • Frequency Analyzer-Controlled
  • Usage Type Clinical Laboratory, In Vitro Diagnostic Use Only
  • Function FK506 (Tacrolimus) Quantification
  • Shelf Life 12 Months (from manufacturing date)
  • Features High specificity and sensitivity, CLIA based, automated workflow
  • Measurement Range 1.00-40.00 ng/mL (varies by analyzer validation)
  • Accuracy Refer to IFU / Analyzer validation data
  • Click to View more
X

Snibe MAGLUMI FK506 (CLIA) Price And Quantity

Snibe MAGLUMI FK506 (CLIA) Product Specifications

  • CLIA (Chemiluminescence Immunoassay)
  • No
  • Analyzer Powered
  • No
  • Yes
  • Automatic (Analyzer Dependent)
  • Clinical Laboratory, In Vitro Diagnostic Use Only
  • Analyzer-Controlled
  • 12 Months (from manufacturing date)
  • High specificity and sensitivity, CLIA based, automated workflow
  • Analyzer Specific
  • Chemiluminescence Immunoassay (CLIA) Reagent Kit
  • White/Reagent Kit Labels
  • Kit packaging, varies
  • FK506 (Tacrolimus) Quantification
  • Refer to IFU / Analyzer validation data
  • Analyzer Specific
  • 1.00-40.00 ng/mL (varies by analyzer validation)
  • Diagnostic Grade Chemical Reagents
  • MAGLUMI Series (e.g., MAGLUMI 800, 2000 Plus, 4000)
  • Store at 2-8°C. Do not freeze.
  • Kit packaging, varies
  • Analyzer Display
  • New
  • Quantitative determination of FK506 (Tacrolimus) in human whole blood
  • See outer package / label
  • 2-point calibration (kit provided)
  • Level 1 & 2 controls available separately
  • Validated on Snibe MAGLUMI analyzers only
  • 130221003M
  • 100 Tests / Kit
  • See package label
  • Monitoring of immunosuppressive therapy
  • FK506 (Tacrolimus)
  • Human Whole Blood
  • ~40 minutes

Product Description

Brand Snibe
Sample Type Whole Blood
Pack Size 100T
CAT No. 130207003M
Application Drug Test

The kit has been designed for the quantitative determination of FK506 in human whole blood. The method can be used for samples over the range of 0-50ng/ml. The test has to be performed on the MAGLUMI chemiluminescence immunoassay (CLIA) fully auto analyzer (Including MAGLUMI 1000, MAGLUMI 2000, MAGLUMI 2000 Plus and new developed models).



Precise Monitoring for Immunosuppressive Therapy

The Snibe MAGLUMI FK506 (CLIA) Reagent Kit enables clinicians to accurately quantify Tacrolimus in whole blood samples. This is vital for optimizing immunosuppressive treatment in transplant patients, assisting in dose adjustments to achieve the best possible patient outcomes while minimizing adverse effects. Automated analysis ensures efficient and reproducible results.


Streamlined Workflow with Advanced CLIA Technology

Relying on chemiluminescence immunoassay (CLIA), the kit delivers rapid results (approximately 40 minutes) and integrates seamlessly with Snibe MAGLUMI analyzers. Its 2-point calibration and optional level 1 & 2 controls ensure robust quality management and confidence in every measurement, making it an ideal choice for routine laboratory operations.

FAQ's of Snibe MAGLUMI FK506 (CLIA):


Q: How is the Snibe MAGLUMI FK506 (CLIA) kit used in clinical laboratories?

A: The kit is used for the quantitative measurement of FK506 (Tacrolimus) in human whole blood, primarily for monitoring patients undergoing immunosuppressive therapy. Laboratories run the assay on validated Snibe MAGLUMI analyzers, following standard operating procedures for automated and precise results.

Q: What is the process for running the FK506 assay on a MAGLUMI analyzer?

A: First, whole blood samples are prepared according to the Instructions for Use (IFU). The analyzer is loaded with the reagent kit, and a 2-point calibration is performed using the provided calibrators. Samples are then processed automatically, and results are obtained in about 40 minutes.

Q: When should Tacrolimus levels be measured using this kit?

A: Typically, Tacrolimus levels are monitored at regular intervals as determined by clinical protocols, especially in patients who have received organ transplants. Regular testing helps ensure therapeutic drug levels are maintained to prevent organ rejection or drug toxicity.

Q: Where can I find information about the kit's lot number and expiry date?

A: Lot number details are indicated on the package label, while expiry information is available on the outer package or label. Always check these details before use to ensure reagent validity.

Q: What are the key benefits of using this CLIA-based FK506 reagent kit?

A: The kit offers high specificity and sensitivity, automated workflow, and reliable quantification of Tacrolimus, aiding effective patient management. It reduces manual intervention, assures consistent results, and integrates easily with MAGLUMI analyzers for streamlined operations.

Q: Are level 1 and 2 controls included in every kit, and why are they important?

A: Level 1 and 2 controls are available separately, not included in every kit. Running these controls ensures ongoing assay accuracy and reliability, facilitating quality assurance in clinical test results.

Q: What are the recommended storage conditions for the FK506 (CLIA) kit?

A: Store the kit between 2-8C and avoid freezing. Proper storage is crucial to maintain reagent stability and guarantee accurate assay performance throughout the stated shelf life.

Tell us about your requirement
product

Price:

Quantity
Select Unit

  • 50
  • 100
  • 200
  • 250
  • 500
  • 1000+
Additional detail
Mobile number

Email

Other Products in 'Medical CLIA' category



trade india member
SAASKIN CORPORATION PRIVATE LIMITED All Rights Reserved.(Terms of Use)
Developed and Managed by Infocom Network Private Limited.